Cargando…

13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation

BACKGROUND: The Paul-Ehrlich-Institut (PEI) published an analysis of reports of adverse drug reactions (ADRs) in 2001 with test and therapy allergens from the period from 1991 to 2000. Possible risk factors were evaluated for the ADR reports classified as “serious”. During the analyzed period, modif...

Descripción completa

Detalles Bibliográficos
Autores principales: Distler, Andreas, Pappelendam, Debbie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792348/
https://www.ncbi.nlm.nih.gov/pubmed/27069842
http://dx.doi.org/10.1007/s40629-015-0084-y